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Background: Body dissatisfaction is common among both females and males. Dissatisfaction with the body is a
risk factor both for onset of eating disorders and for abuse of anabolic androgenic steroids (AAS). Few studies have
however investigated if there are other similarities in respect to self-image or psychiatric symptoms between clinical
samples of eating disordered males and males in treatment for negative effects of AAS use.
Aim: The aim of this study was to compare two clinical samples, one of males with ED and one of males who used
AAS, regarding self-image and psychiatric symptoms.
Methods: This study compared males with eating disorders (n = 13) and males who recently stopped AAS use
(n = 29) on self-image and psychiatric symptoms, using The Structural Analysis of Social Behavior self-questionnaire
and a shortened version of The Symptom Check List.
Results: The eating disorder group reported significantly lower scores for Self-emancipation and Active self-love
and higher scores for Self-blame and Self-hate. Both groups reported serious psychiatric symptoms. The common
denominator between groups was serious psychiatric symptomatology rather than negative self-image.
Conclusions: The negative self-image profile, especially self-hate, found among males with Eating Disorders may
indicate that the studied groups differ in aetiology of the underlying problems. The serious psychiatric symptoms in
both groups call staff to pay attention to any thoughts of suicide due to severe depressive symptoms where by
specialized psychiatric treatment may be needed.
Keywords: Male eating disorders, Anabolic androgenic steroids, Self-image, Psychiatric symptomsBackground
Dissatisfaction with the body is very common in the
population, in females in all ages [1] as well as among
males [2]. Studies on female and male body image show
the role of the media in defining and perpetuating body
ideals [3], e.g., a muscular ideal male body type [4], or a
thin female ideal [5]. A meta-analysis of the effects of
the media on male body image concerns, yielded similar
effect sizes as those found with women [6]. As a result
of internalization of cultural norms, females become
dissatisfied with the lower part of their bodies from the* Correspondence: tabita.bjork@orebroll.se
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reproduction in any medium, provided the orwaist down and try to lose weight while males primarily
want to change the shape of upper part of their bodies
(stomach and chest) and are more likely to desire an
increase in weight [7]. Body dissatisfaction has been
reported as a risk factor, and one of the strongest pre-
dictors for onset of an eating disorder (ED) [8-10] and
is also associated with low self-esteem and depression
[8,11]. Dissatisfaction with the body seems to be the
common and prominent denominator, not only between
the sexes, but also between males with ED [12] and
males using anabolic androgenic steroids (AAS) [13].
Both ED and the use of AAS may seriously affect physical
health and the psychological and social wellbeing of those
who suffer from those problems [14,15].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ED is a long-lasting mental disorder, characterized with
disturbed eating or weight controlling behavior [14].
Studies have shown that ED are most common among
young women, and that only about 10 per cent of patients
with ED seen in mental health care are males [16].
Some have found that only 16 per cent of males with
ED in fact seek treatment [17]. The proportion of
males, 18 years or older in specialist treatment for ED
in Sweden has been lower (1.5%) [18], than expected
from prevalence studies [16]. A report from Swedish
Quality registry on ED indicates an increase in the
amount of males seeking treatment, since 4% of the
adult patients in specialist ED-treatment in Sweden last
year were males [19].
Earlier research studies on ED often excluded males
and our knowledge about males with eating disorders
is therefore still sparse [12,20]. However, research has
begun focusing on males with ED and similarities between
genders have been found, such as multi-factorial causes
of ED, the core symptoms of ED, and suggestions that
the course of illness, treatment response and long-term
prognoses are comparable, which means that ED among
males are also associated with an increased risk of mor-
tality [21-24]. Differences between genders have how-
ever also been reported [25,26]. A history of premorbid
overweight is more common among males with ED
[23], and they report significantly lower scores on drive
for thinness than females with ED, since they rather
strive for a lean muscularity [27-29]. Males often use
exercise as a compensatory method, while females vomit
to control their body weight. Males are also more likely to
binge eat than females [12,30-32]. Stanford and Lemberg
[27] conclude that ED symptoms in males especially
differ from females with ED in the construct of body
dissatisfaction and the compensatory behavior associated
with bulimia. Some results also indicate prognosis and
outcome to be more favorable for males with shorter
time to recovery and higher proportion of males reaching
recovery [33].
AAS among males
AAS, synthetic derivatives of the male endogenous sex
hormone testosterone, were originally used by athletes
but are now used by a far wider range of groups outside
of sports and athletics [34,35]. The majority of AAS
users are males [36-38]. In Sweden, between 50 000 –
100 000 people are thought to have used AAS, about 1%
of the population of 9 million [39]. Lifetime prevalence
of AAS use among males in USA is estimated to 0.9%
and to 0.1% among females in the general population,
while the prevalence of AAS use in Poland is 6% among
males and 3% among females [40]. In Western countries
life time prevalence of AAS in males ranges from 1% to5%, and among females the prevalence is estimated to
0.1% [41]. The users reason for using AAS is to improve
their appearance as well as performance [39,42]. Serious
physical (i.e. cardiovascular, reproduction and endocrine
system), psychiatric (i.e. depression, aggression and sleeping
problems) [15] and social side effects (i.e. abuse of other
drugs, battering of spouses and other criminality) [43]
of AAS misuse have been reported. Heightened levels
of violent behaviors are also reported among AAS-
users [44].
Comparisons between males with ED, male bodybuilders
and normal controls revealed that bodybuilders more
closely resembled the ED group than normal controls
regarding body dissatisfaction and loss of sexual desire
[45]. Few studies have so far investigated why some of
the body dissatisfied males become oriented towards
thinness and why others become focused on muscularity.
One study indicates that the groups may differ regarding
body ideals [2].Are there other differences or similarities?
AAS use can be associated with body image disorders
as “Muscle Dysmorphia” [46,47], sometimes also called
“reverse anorexia nervosa”, which is defined as a fear of
being too small [48]. The authors discuss the possibility
that this “reverse anorexia nervosa” in males may be a
similar disorder to anorexia nervosa in females and
account for the lower prevalence rates of anorexia
nervosa in males.
Other similarities found between males with ED and
body-builders including AAS users were characteristics
such as perfectionism, ineffectiveness and low self-esteem
[42]. An essential question is whether more similarities
can be found between males with ED and AAS users or
if these groups differ in some essential respects. It is for
example unclear whether there is a distinction between
males with ED and males using AAS regarding the occur-
rence of underlying interpersonal profiles like negative
self-image and the severity of psychiatric symptoms. Based
on earlier studies showing several similarities between
these groups, we anticipated that negative self-image
and psychiatric symptoms would be similar between
males with eating disorders and males who recently
used AAS.
The aim of this study was to compare two clinical
samples of males, one of males with ED and one of males
who used AAS, regarding self-image and psychiatric
symptoms.Methods
Sample
Male adult ED patients (n = 13) and males who recently
terminated use of AAS (n = 29) were included in the
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treatment was used for both groups in the present study.
Selection of the ED group and sample characteristics
The males with ED were collected from the Co-ordinated
Evaluation and Research at Specialized Units for Eating
Disorders (CO-RED) project. This naturalistic longitudinal
project studied 840 adult patients seeking treatment at
14 specialized centers for ED across Sweden. All thirteen
males who started treatment (1.5%) were included in
the study. The males showed the typical ED psychopath-
ology with weight phobia, binge eating, compensatory
behavior and body image dissatisfaction, and were all
diagnosed with an ED according to DSM-IV [49]: 3 (23%)
had Anorexia Nervosa, 3 (23%) had Bulimia Nervosa
and 7 (54%) were diagnosed with Eating Disorder Not
Otherwise Specified. Age at onset of their ED varied
between 8 to 19 years, and the average duration of the
ED at treatment start was 11.5 years (Md). Age at treat-
ment start was 20.5 years (Md) and varied between 18
to 35 years. None of the males in the ED group
reported any history of drug abuse. Further information
about the CO-RED project is described in more detail
elsewhere [18].
Selection of the AAS group and sample characteristics
AAS users were consecutively included from a doping
clinic in an addiction centre (AC) in Örebro County. A
total of 36 AAS users who recently terminated use of
AAS were attending the AC to seek help for different
AAS-related side effects. This included somatic, psychi-
atric, and/or social problems, for example gynecomastia,
depression or relationship problems. At the AC they were
all screened for psychiatric problems (including the
presence of Eating Disorders or Muscle Dysmorphia).
All AAS users were also screened for drug use several
times. Twenty-nine of these patients (80.5%), all males
were selected for the study. All 29 had used different
AAS (human and/or veterinarian drugs), 28 (97%) used
pharmaceuticals, 27 (93%) used narcotics, 13 (45%)
used alcohol in a hazardous or harmful way and only
one had never used narcotics or pharmaceuticals. They
were all treated for different AAS related problems and
diagnosed according to DSM IV [49]; one (3%) had
Muscle Dysmorphia , two (7%) had ADHD , six (21%)
had Anxiety Disorders, 10 (34%) were diagnosed with
substance related disorders and 10 (34%) did not get
any psychiatric diagnosis. In the somatic screening nine
(31%) showed sexual related problems, five (17%) testicle
atrophy, four gynecomastia (14%), five (17%) heart related
problems (17%), 6 (21%) had acne, five (17%) liver related
problems and six (21%) had striae problems. Eight
(28%) of the 29 had no somatic problems. Twenty-eight
(97%) were condemned for different crimes (e.g. crimesof violence, weapon offences or drug-related offences).
The criminality in this sample has been studied and de-
scribed in more detail elsewhere [50].
Measures
The Symptom Check List (SCL) was used to measure
self-reported psychiatric symptoms. A shortened, 63-
item version of the SCL-90 [51] was utilised by removing
the subscales for Phobic Anxiety, Paranoid Ideation,
Psychoticism and Additional Scales.
The Structural Analysis of Social Behavior (SASB),
(Intrex version, 3rd surface, self-image) was used to assess
self-image [52,53]. The questionnaire comprises 36 self-
referential statements, some framed positively and others
negatively. Responses are given on a scale from 0 to 100
with 10-point increments. Responses of 40 or above repre-
sent confirmation of the statement, whereas responses
below 40 designate non-confirmation. The questionnaire
forms eight clusters of self-image: (1) Self-emancipation,
(2) Self-affirmation, (3) Active self-love, (4) Self-protection,
(5) Self-control, (6) Self-blame, (7) Self-hate, and (8) Self-
neglect. Cluster scores are obtained by dividing the sum of
the items comprising the cluster by the number of items
in the cluster. Recent empirical studies support the reli-
ability of the SASB self-image questionnaire with a total
Cronbach’s alpha = .74 [54].
The study protocol was approved by the Ethics Com-
mittee of Orebro County Council (No.: 538/99) and the
Regional Ethics Vetting Board in Uppsala (No.: 2004:
M-316) in accordance with the Swedish law concerning
approval of medical research. The participants all gave
their informed consent.
Analysis
Data were analysed using SPSS for Windows version
17.0. Between-group comparisons were made using chi-
square tests for categorical data, with Fisher’s exact test
where appropriate. Independent two-tailed t-tests were
used when comparing groups on age, Body Mass Index
(BMI = kg/m2), dimensions of self-image and psychiatric
symptoms, and effect sizes were computed for differences
using Cohen’s d, in between-group comparisons [55]. We
choose to show the exact p-value in all analyses.
Results
Independent t-tests revealed that males with ED were
significantly younger than the AAS group. An expected
dissimilarity was also found regarding BMI; AAS group
had significantly higher weight and BMI. The sample
characteristics are shown in Table 1.
Between-group comparisons on self-image
Results from independent t-tests showed significant
between-group differences with moderate to large effect
Table 1 Sample characteristics
ED group (n = 13) M (SD) range AAS group (n = 29) M (SD) range p-value
Age 22.7 (5.52) 18−35 26.1 (4.47) 19−36 0.04
Height (m) 1.78 (0.11) 1.60−1.98 1.79 (0.06) 1.64−1.90 0.73
Weight (kg) 63.5 (15.06) 38−95 98.8 (17.36) 62−140 0.01
BMI 21.0 (6.78) 14.36−41.33 30.8 (4.87) 21.13−43.06 0.01
Comparisons between groups on age, height, weight and BMI by independent t-tests.
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measured by SASB. The ED group reported significantly
higher scores on Self-blame and Self-hate, as well as
lower scores on Self-emancipation and Active self-love
compared with the AAS group, which indicate a negative
self-image in the ED group, but not in the AAS group
(Table 2). Figure 1 illustrates the self-image profiles for
the ED group and the AAS group.
Between-group comparisons on psychiatric symptoms
The results from independent t-test indicated no significant
differences in psychiatric symptoms measured with SCL-63
between groups. Detailed results are presented in Table 2.
Figure 2 illustrates the distribution of mean values and
effect sizes for the differences between the ED group
and the AAS group for each dimension of the SCL-63.
Discussion
The present study aimed to compare self-image and psy-
chiatric symptoms in males with ED and males who had
used AAS. Our most important finding was that the EDTable 2 Self-image and psychiatric symptoms







Self emancipation 27.7 (11.5) 40.6 (17.2)
Self affirmation 21.0 (18.4) 33.4 (26.7)
Active self-love 24.5 (16.7) 43.9 (23.8)
Self-protection 42.1 (14.0) 48.2 (18.2)
Self-control 55.8 (21.4) 45.9 (19.4)
Self-blame 59.2 (29.25) 38.5 (21.8)
Self-hate 56.5 (23.1) 36.9 (20.5)
Self-neglect 38.9 (19.6) 39.1 (23.6)
SCL-63
Somaticism 1.25 (0.7) 1.32 (0.82)
Obsession- compulsion 1.86 (0.8) 1.66 (0.93)
Anxiety 1.59 (0.7) 1.65 (0.94)
Interpersonal sensitivity 1.69 (0.8) 1.46 (0.87)
Depression 1.93 (0.8) 1.74 (0.88)
Hostility 0.73 (0.7) 1.28 (1.12)
Between-group comparisons with two group independent t-tests from intake on th
*d < 0.2 indicates no difference, d = 0.2-0.49 indicates a small difference, d = 0.5-0.8group showed a considerably more negative self-image
at treatment start than the AAS group, but the two
groups were similar with respect to serious psychiatric
symptoms. These results suggest that the common denom-
inators between these two groups are serious psychiatric
symptoms, particularly anxiety, depression, interpersonal
sensitivity and obsessive-compulsive behavior rather than
a negative self-image.
The negative self-image, especially self-hate, found among
males with ED in this study is in line with other studies
describing similar negative self-image profiles among
females with ED [56]. Comparisons with published data
for normal controls of self-image [56] indicate that our
ED group differs considerably from normal controls
on SASB on all dimensions of self-image, while the AAS
group seems to differ most from normal controls with
regard to less Self-affirmation. The typical feature of self-
hate that was reported earlier among ED patients [56] is
not that strongly marked in the AAS group, which may
indicate that the aetiology of the underlying problems in








−23.5 − −2.25 .019 −2,45 (40) .90
−29.0 − 4.0 .135 −1,53 (40) .55
−34.3 − −4.7 .011 −2,66 (40) .96
−17.6 – 5.4 .292 −1,07 (40) .38
−3.6 – 23.4 .146 1.48 (40) .50
4.3 – 37.1 .015 2,55 (40) .81
5.3 – 34.0 .009 2,76 (40) .90
−15.3 – 15.1 .988 −,02 (40) .01
−.61 − .49 .813 −.24 (39) .09
−.42 − .83 .514 ,66 (39) .23
−.67 − .55 .821 −,23 (39) .07
−.36 − .82 .436 ,79 (39) .28
−.39 − .78 .504 ,66 (39) .23
−1.26 − .16 .062 −1,93 (39) .60
e SASB and the SCL-63.
indicates a moderate difference, and d > 0.8 indicates a large difference [55].
Figure 1 Dimensions of self-image measured by SASB. The
distribution of mean values for each dimension of the SASB for the
ED group and the AAS group. A normal self-image according to the
SASB model is characterized by high values (≥ 40) on the positive
clusters and low values (≤ 40) on the negative clusters.
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chiatric complications and use of AAS, e.g. mood changes
and aggression [57] or even violence and, during AAS
withdrawal, an association with depression [58]. AAS
users in this study described that the psychiatric problems
started or deteriorated after they started with AAS use.
This study points out the need to further examine these
groups in a larger sample with a prospective design. Such
design could determine whether the co-occurrence of psy-
chiatric symptoms, earlier reported among body-builders
using steroids [42] and in eating disorders [12], are an
effect of body dissatisfaction with conflicts between
internalization of cultural norms or if these symptoms
are consequences of living with an ED or having a history
of AAS use.
Clinical implications: These results highlight the need
to detect these patients wherever they seek treatment.
A challenge for health care is to reach these groups,
and to intervene early before the consequences become
severe. Results call staff to pay attention to any thoughts





































Figure 2 Dimensions of psychiatric symptoms measured by SCL. The
ED group and the AAS group.problems are of such severity that specialized psychi-
atric treatment may be needed.Limitations
Although this study shows significant differences in self-
image between the ED- and the AAS group, and discloses
severe psychiatric symptoms in both groups, it has cer-
tain limitations. The small sample size, reflecting the
rarity of these clinical samples, limits the possibilities of
generalization. However, males in specialist treatment for
ED in Sweden are quite rare and the fact that this study
included all males who were treated nationwide supports
a representativeness of the ED group for treatment-
seeking males with ED in Sweden. Another limitation
concerns the selection of the AAS group. They were all
seeking treatment for negative side-effects of steroid
use and are therefore more likely to be representative
of AAS users seen in health care, but not for those who
may recently have started steroid use and predomin-
antly experience positive effects [59]. A strength of this
study is that it adds new pieces of knowledge not previ-
ously presented.Conclusions
This study highlights both the differences and similarities
between the two groups studied: significantly different
self-image profiles but similar psychiatric symptoms.
However, the serious psychiatric symptoms, equally pre-
valent in both groups, emphasize the need to examine the
severity of psychiatric symptoms and offer psychiatric
treatment for those in need, regardless of whether these
psychiatric symptoms are a reason for the illness or a
consequence of living with ED or AAS-use. It is important
that more research focus on these specific groups, to
ensure proper assessment and treatment. Future research
needs to investigate further the role of self-image in pro-



















distribution of mean values for the six dimensions of the SCL for the
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